Highlights:Phase 1 construction now approximately 92% completeNanofiltration plant assembly progressing to planConstruction ...
In April of this year, the Food and Drug Administration (FDA) announced a new roadmap that aims to replace animal testing in the development of new drugs with more human-relevant methods. The goal is ...
Iadademstat, a selective LSD1 inhibitor, is being tested with immune checkpoint inhibitors for extensive-stage SCLC in a phase 1/2 trial. The trial, led by the National Cancer Institute, evaluates ...
Highlights:Phase 1 construction now approximately 92% completeNanofiltration plant assembly progressing to planConstruction expected to complete in the short term, transitioning to testing and commiss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results